• My Ankylosing Spondylitis Diagnosis Journey, Part 2
  • The Joys and Perils of Turning to Online Groups for Support
  • TNF-alpha Inhibitors May Increase Eosinophil Levels in Ankylosing Spondylitis Patients, Study Suggests
  • My Ankylosing Spondylitis Diagnosis Journey, Part 1
  • Genetic Marker HLA-B27 Correlates With Ankylosing Spondylitis Onset but Not Disease Burden, Study Shows
  • Phase 3 Trial Evaluating Xeljanz’s Efficacy in Patients with Active Ankylosing Spondylitis Now Enrolling
  • Ixekizumab Benefits Ankylosing Spondylitis Patients Who Failed to Respond to Standard Therapy, Phase 3 Study Shows
  • #NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach
  • Anti-Rheumatic or Anti-Tumor Necrosis Therapy Does Not Contribute to Increased Infection Risk, Study Shows
  • Filgotinib Safe, Effective in Treating Ankylosing Spondylitis, Phase 2 Trial Shows
  • Cosentyx Safe, Effective Through 5 Years of Treatment, Novartis Announces
  • Low Levels of Specific Immune Cell Linked to Ankylosing Spondylitis Manifestations, Mouse Study Suggests